Literature DB >> 1586182

Intravenous aminophylline and cerebral blood flow in preterm infants.

M McDonnell1, N K Ives, P L Hope.   

Abstract

The effect of aminophylline on cerebral blood flow (CBF) was studied in 10 preterm infants who were receiving 6.2 mg/kg intravenously over 20 minutes followed by a maintenance infusion. CBF was measured intermittently using near infrared spectroscopy. Heart rate, blood pressure, oxygen saturation, and transcutaneously measured carbon dioxide tension (TcPCO2) were recorded continuously. Aminophylline administration was associated with a fall in CBF from a median of 15.9 ml/100 g/min to 11.2 ml/100 g/min. Median fall in CBF was 4.1 ml/100 g/min (95% confidence interval 1.7 to 6.5). Heart rate rose and TcPCO2 fell in all infants, median fall being 0.66 kPa. The reduction in CBF was greater than would be expected on the basis of the modest fall in TcPCO2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586182      PMCID: PMC1590491          DOI: 10.1136/adc.67.4_spec_no.416

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man.

Authors:  R L WECHSLER; L M KLEISS; S S KETY
Journal:  J Clin Invest       Date:  1950-01       Impact factor: 14.808

2.  Effects of indomethacin on cerebral haemodynamics in very preterm infants.

Authors:  A D Edwards; J S Wyatt; C Richardson; A Potter; M Cope; D T Delpy; E O Reynolds
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

3.  Regional cerebral blood flow velocity after aminophylline therapy in premature newborn infants.

Authors:  V Ghai; T N Raju; S Y Kim; K M McCulloch
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

4.  Cerebral blood flow reactivity in spontaneously breathing, preterm infants shortly after birth.

Authors:  O Pryds; G E Andersen; B Friis-Hansen
Journal:  Acta Paediatr Scand       Date:  1990-04

5.  Aminophylline reduces cerebral blood flow in stable, preterm infants without affecting the visual evoked potential.

Authors:  O Pryds; S Schneider
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

6.  Aminophylline reduces cerebral blood flow velocity in low-birth-weight infants.

Authors:  T S Rosenkrantz; W Oh
Journal:  Am J Dis Child       Date:  1984-05

7.  Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.

Authors:  R A Jones; E Baillie
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

8.  Cardiac output changes secondary to theophylline therapy in preterm infants.

Authors:  F J Walther; M E Sims; B Siassi; P Y Wu
Journal:  J Pediatr       Date:  1986-11       Impact factor: 4.406

9.  Effect of caffeine on cerebral blood flow velocity in preterm infants.

Authors:  E Saliba; E Autret; F Gold; D Bloc; L Pourcelot; J Laugier
Journal:  Biol Neonate       Date:  1989

10.  Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry.

Authors:  J S Wyatt; M Cope; D T Delpy; S Wray; E O Reynolds
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

View more
  4 in total

1.  Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants.

Authors:  C Hoecker; M Nelle; B Beedgen; J Rengelshausen; O Linderkamp
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01       Impact factor: 5.747

2.  Near infrared spectroscopy.

Authors:  A D Edwards
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 3.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Effect of aminophylline on cerebral haemodynamics and oxidative metabolism in premature infants.

Authors:  H U Bucher; M Wolf; M Keel; K von Siebenthal; G Duc
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.